PubMed · PMID 7652467
The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.
PMID 7652467Journal Tumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineYear 1995Authors 6
Abstract
The serum levels of soluble interleukin-2 (sIL-2), sIL-2 receptors (sIL-2R), beta 2-microglobulin (beta 2M) and soluble intercellular adhesion molecule-1 (sICAM-1) were measured by the ELISA technique in 129 breast cancer patients and 40 controls. The median serum levels of sIL2-R, beta 2M and sICAM-1 were significantly higher and sIL-2 significantly lower than controls. sIL-2R, sICAM-1 and beta 2M levels were significantly higher in patients with metastatic disease compared to patients on long-term follow-up with no active disease. Initial study measurements of these markers could not identify patients at high risk for relapse.
These findings suggest that the sIL-2R level is indicative of metastatic disease and together with other parameters of immune activation may be of help in monitoring disease activity in breast cancer patients.
Record details
| PMID | 7652467 |
|---|---|
| PMCID | not held |
| DOI | not stated |
| Journal | Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine |
| Year | 1995 |
| Authors | B Klein; I Levin; B Kfir; M Mishaeli; J Shapira; T Klein |
| Licence | not stated |
| MeSH | Adult; Aged; Breast Neoplasms; Humans; Intercellular Adhesion Molecule-1; Interleukin-2; Middle Aged; Neoplasm Metastasis; Receptors, Interleukin-2; beta 2-Microglobulin |
Source record
Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.